Xiang Yang Lu
Chief Executive Officer at LAEKNA, INC.
Net worth: 43 M $ as of 2024-05-30
Xiang Yang Lu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LAEKNA, INC. | Chief Executive Officer | 2016-07-28 | - |
| Chairman | 2016-07-28 | - | |
| Founder | 2016-07-28 | - | |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
| Chief Executive Officer | 2016-11-30 | - | |
| Founder | 2016-11-30 | - | |
| Laekna Ltd. | Director/Board Member | - | - |
Career history of Xiang Yang Lu
Former positions of Xiang Yang Lu
| Companies | Position | Start | End |
|---|---|---|---|
| China Novartis Institutes for BioMedical Research Co., Ltd. | Director/Board Member | 2003-08-31 | 2016-02-29 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Director/Board Member | 2003-08-31 | 2016-02-29 |
| Frontline Bioventures | Corporate Officer/Principal | 2015-12-31 | - |
Training of Xiang Yang Lu
| Nankai University | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistics
International
| China | 5 |
| United States | 3 |
| Cayman Islands | 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| Frontline Bioventures | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Laekna Ltd. | |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Stock Market
- Insiders
- Xiang Yang Lu
- Experience
